Goldman Sachs’s Celgene Corp CELG Stock Holding History

Goldman Sachs’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-84,900	Closed	-$8.43M	–	5592
2019 Q3	$8.43M	Buy	84,900 +25,300	+42%	+$2.4M	﹤0.01%	2452
2019 Q2	$5.51M	Sell	59,600 -192,200	-76%	-$18.3M	﹤0.01%	2780
2019 Q1	$23.8M	Sell	251,800 -186,800	-43%	-$16.3M	0.01%	1730
2018 Q4	$28.1M	Buy	438,600 +94,900	+28%	+$7.01M	0.01%	1532
2018 Q3	$30.8M	Sell	343,700 -80,500	-19%	-$7.11M	0.01%	1592
2018 Q2	$33.7M	Sell	424,200 -71,100	-14%	-$5.9M	0.01%	1519
2018 Q1	$44.2M	Sell	495,300 -106,500	-18%	-$10.2M	0.01%	1280
2017 Q4	$62.8M	Buy	601,800 +45,700	+8%	+$5.16M	0.02%	1119
2017 Q3	$81.1M	Buy	556,100 +8,300	+2%	+$1.13M	0.02%	940
2017 Q2	$71.1M	Sell	547,800 -143,200	-21%	-$17.5M	0.02%	1016
2017 Q1	$86M	Sell	691,000 -325,000	-32%	-$38.9M	0.02%	855
2016 Q4	$118M	Buy	1,016,000 +445,100	+78%	+$49.6M	0.03%	668
2016 Q3	$59.7M	Sell	570,900 -101,400	-15%	-$11M	0.02%	1066
2016 Q2	$66.3M	Buy	672,300 +264,400	+65%	+$27.3M	0.02%	914
2016 Q1	$40.8M	Sell	407,900 -142,600	-26%	-$14.7M	0.01%	1220
2015 Q4	$65.9M	Sell	550,500 -256,900	-32%	-$29.7M	0.02%	926
2015 Q3	$87.3M	Buy	807,400 +297,400	+58%	+$36.9M	0.03%	696
2015 Q2	$59M	Sell	510,000 -260,000	-34%	-$29.7M	0.02%	1001
2015 Q1	$88.8M	Sell	770,000 -182,700	-19%	-$21.8M	0.03%	711
2014 Q4	$107M	Buy	952,700 +105,400	+12%	+$11.1M	0.03%	644
2014 Q3	$80.3M	Buy	847,300 +179,600	+27%	+$16.2M	0.03%	758
2014 Q2	$57.3M	Sell	667,700 -87,900	-12%	-$6.68M	0.02%	991
2014 Q1	$52.7M	Sell	755,600 -117,200	-13%	-$9.28M	0.02%	1024
2013 Q4	$73.7M	Sell	872,800 -86,200	-9%	-$6.82M	0.02%	789
2013 Q3	$73.9M	Sell	959,000 -333,000	-26%	-$23.3M	0.03%	723
2013 Q2	$75.6M	Buy	+1,292,000	New	+$77.7M	0.03%	673

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Goldman Sachs's CELG Position: Q4 2019 in Review

Goldman Sachs sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,449,861 shares — an estimated $740M sold.

Goldman Sachs first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $892M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Goldman Sachs reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Goldman Sachs sold 7,449,861 Celgene Corp shares in Q4 2019, an estimated $740M.
Goldman Sachs first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
Goldman Sachs's Celgene Corp position peaked at $892M in Q1 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.